Antivirals for HIV Treatment and Prevention [ 2017 - 2021 ]

Research Grant

Researchers: Prof Gilda Tachedjian (Principal investigator)

Brief description HIV/AIDS remains a major global threat with ?37 million individuals living with HIV in 2014. Antiretroviral drugs have transformed HIV from a death sentence into a chronic disease. Public health organisations recommend dramatic scale up of drugs for HIV treatment and prevention. However, a major threat is that drug options will be exhausted in the long-term due to drug resistance and toxicity. The major aim of this study is to advance the development of an entirely new drug class for HIV.

Funding Amount $AUD 722,379.56

Funding Scheme Research Fellowships

Notes Research Fellowship